Informatie:
Fout:
ID
34273
Beschrijving
Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With Metformin; ODM derived from: https://clinicaltrials.gov/show/NCT02111967
Link
https://clinicaltrials.gov/show/NCT02111967
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes Mellitus Type 2 NCT02111967
Eligibility Diabetes Mellitus Type 2 NCT02111967
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus Type 2 NCT02111967
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
diagnosis of t2dm > 6 months
boolean
ID.2
Item
metformin treatment for at least 6 months
boolean
ID.3
Item
age > 18 years
boolean
ID.4
Item
ability to give written informed consent
boolean
ID.5
Item
no metformin treatment in the last 6 months (control group)
boolean
ID.6
Item
concurrent intake of preparations containing vb12 (within the last 3 months prior to study participation)
boolean
ID.7
Item
lack of written and/or oral understanding in german, french, italian or english languages
boolean
ID.8
Item
diagnosis of transcobolamin transporter defect
boolean
ID.9
Item
diagnosis of chronic or acute liver diseaseliver insufficiency with child-pugh scores b and c and acute hepatitis
boolean
ID.10
Item
diagnosis of renal disease (creatinine-clearance <60 ml/min)renal insufficiency stadium iii, iv and v (kdoqi) and acute renal diseases
boolean